The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.
The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These ...
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of ...
The US Food and Drug Administration has recalled thousands of bottles of Duloxetine antidepressant, saying it contained high ...
Release Capsules - sold under the brand name Cymbalta - have been recalled due to containing a potentially cancer-causing ...
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by ...
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high ...